HY-100218A-10mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
HY-100218A-100mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
HY-100218A-2mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
HY-100218A-25mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
HY-100218A-5mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
HY-100218A-50mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
HY-100574A-1mg
|
MedChemexpress LLC
|
Cl-amidine (hydrochloride) [CAS 1373232-26-8]
|
|
COVID-19-immunoregulation
|
|
HY-100574A-10mg
|
MedChemexpress LLC
|
Cl-amidine (hydrochloride) [CAS 1373232-26-8]
|
|
COVID-19-immunoregulation
|
|
HY-100574A-100mg
|
MedChemexpress LLC
|
Cl-amidine (hydrochloride) [CAS 1373232-26-8]
|
|
COVID-19-immunoregulation
|
|
HY-100574A-25mg
|
MedChemexpress LLC
|
Cl-amidine (hydrochloride) [CAS 1373232-26-8]
|
|
COVID-19-immunoregulation
|
|
HY-100574A-5mg
|
MedChemexpress LLC
|
Cl-amidine (hydrochloride) [CAS 1373232-26-8]
|
|
COVID-19-immunoregulation
|
|
HY-100574A-50mg
|
MedChemexpress LLC
|
Cl-amidine (hydrochloride) [CAS 1373232-26-8]
|
|
COVID-19-immunoregulation
|
|
HY-101257-1mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101257-10mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101257-25mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101257-5mg
|
MedChemexpress LLC
|
YKL-5-124 [CAS 1957203-01-8]
|
|
Neuroscience-Neuromodulation
|
|
HY-101257B-10mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
HY-101257B-100mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
HY-101257B-25mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
HY-101257B-5mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
HY-101257B-50mg
|
MedChemexpress LLC
|
YKL-5-124 (TFA) [CAS 2748220-93-9]
|
|
|
|
HY-101454-10mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-100mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-25mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
HY-101454-5mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|